You are here

restructuring

Bloodletting at Zymeworks as new CEO axes half of senior leaders, plans 25% reduction in headcount

Fierce Biotech

Thu, 01/20/22 - 10:47 am

Spectrum hits the reset button, slicing away 30% of its workforce in pivot around 2 lead assets

Endpoints

Wed, 01/5/22 - 10:30 pm

Spectrum Pharmaceuticals

vTv Therapeutics lays off 65% of its workforce two months after leadership change

Bizjournals

Wed, 12/8/21 - 10:46 am

vTv Therapeutics

type 1 diabetes

Deciphera Cutting 35% of Staff Amid Company Restructure

BioSpace

Tue, 11/30/21 - 11:28 pm

Deciphera Pharma

End-of-Year Restructuring Means Layoffs for These Companies

BioSpace

Tue, 11/16/21 - 11:57 am

Rigel Pharmaceuticals

Esperion Therapeutics

Acorda Therapeutics

Ziopharm Oncology

BIO Shakes Things Up to Align Leadership with New Vision

BioSpace

Thu, 01/21/21 - 10:33 am

Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries

Xconomy

Wed, 09/30/20 - 10:58 pm

Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug

Xconomy

Tue, 09/15/20 - 11:03 am

Unity Biotechnology

Medtronic to save up to $475M a year from restructuring

Mass Device

Wed, 09/2/20 - 11:01 am

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

BioSpace

Thu, 06/25/20 - 07:20 pm

Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy

Bloomberg

Wed, 02/12/20 - 10:59 am

GSK cutting 720 jobs in manufacturing, R&D and support functions at massive Belgian vaccine hub

Fierce Pharma

Thu, 02/6/20 - 11:53 am

Amag CEO to step down as troubled pharma looks to sell 2 drugs

BioPharma Dive

Thu, 01/9/20 - 04:03 pm

Amag Pharmaceuticals

Shares of Neon Therapeutics rise on restructuring plans

Marketwatch

Thu, 11/21/19 - 10:33 am

Neon Therapeutics

Merz splits into 3 businesses for better customer focus

Fierce Pharma

Thu, 11/21/19 - 10:18 am

Merz Aesthetics

medical aesthetics

Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut

Xconomy

Mon, 11/4/19 - 10:42 am

Halozyme Therapeutics

pancreatic cancer

clinical trials

Alkermes to lay off 160 in cost-cutting restructure

Biopharma Dive

Wed, 10/23/19 - 02:57 pm

Organovo Halts Liver Tissue R&D, Plans Restructuring to Cut Costs

Xconomy

Thu, 08/8/19 - 10:30 am

organ transplant

liver transplant

As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization

Endpoints

Wed, 07/24/19 - 10:39 am

Dynavax cuts staff in retreat from cancer research

Biopharma Dive

Fri, 05/24/19 - 10:43 am

Dynavax Technologies

Pages